Loading patent…
AssigneeOmega Bio-Pharma (I.P.3) Limited
InventorsBill Piu Chan, Gary Kwan Po Wong, Jinxian Xu, Francis Chi
Estimating the term…
The subject invention provides compositions and methods for treating diabetes in patients. In a preferred embodiment, the invention provides compositions methods for treating diabetes and/or preventing or alleviating complications associated with diabetes. Specifically exemplified herein is the concurrent administration of a cysteamine compound with at least one additional therapeutic agent to prevent and/or treat diabetes as well as prevent and/or treat complications associated with diabetes. In a preferred embodiment, oral administration of cysteamine hydrochloride with Metformin to a patient diagnosed with diabetes can substantially regulate the patient's glucose metabolism and insulin sensitivity.
A method for treating type II diabetes wherein said method comprises concurrently administering to a patient an effective amount of cysteamine, or a salt thereof, with at least one additional therapeutic agent which is Metformin or insulin, and wherein the effective amount of the cysteamine administered to the patient is less than about 400 mg/kg of body weight.
Dependencies are inferred from the claim text.